Breeding Tobacco for Health
The Newcotiana project aims to modify the composition and, therefore, the use we make of tobacco plants, enriching them with substances of high added value. For this, the Newcotiana scientists will employ highly precise breeding technologies, such as the CRISPR technique, and apply them to breeding cultivated tobacco and its relative species N. benthamiana as improved biofactories. In this way, it is intended to revalue the traditional cultivation of tobacco and, at the same time, to improve our manufacturing capacity for health-related bioproducts, such as vaccines, antibodies and other important small molecules with health-promoting properties.
Latest news: Newcotiana partners release the genome of the biofactory plant N. benthamiana for fighting COVID-19 pandemic. More information at: https://nbenth.com
Tobacco; Molecular Farming; CRISPR; New Plant Breeding Techniques. We receive funding from @EU_H2020 Res&Innov Pgrm; tweets reflect only views of project owner
Plant-made vaccines highlighted at the Wall Street Journal https://www.wsj.com/articles/big-tobacco-joins-race-for-coronavirus-vaccine-11586012401
The Wall Street Journal picks up on using plants to make SARS-CoV-2 vaccines!! Well advised by two molecular farmers we know well 😄 https://protect-za.mimecast.com/s/f1ALCvgxAZfXpnz8sQjK_6
Newcotiana explained (in Spanish) NEWCOTIANA, el proyecto europeo que busca utilizar plantas de tabaco como biofactorías | Vía @fundacionantama http://fundacion-antama.org/newcotiana-el-proyecto-europeo-que-busca-obtener-plantas-de-tabaco-como-biofactorias/